Qiangming Sun Selected Research

Qiangming Sun Research Topics

Disease

11	Infections 12/2023 - 01/2016
7	Neoplasms (Cancer) 01/2023 - 11/2009
4	Dengue (Dengue Fever) 01/2022 - 01/2021
3	COVID-19 01/2023 - 01/2020
2	Communicable Diseases (Infectious Diseases) 12/2023 - 12/2021
2	Virus Diseases (Viral Diseases) 10/2022 - 01/2018
2	Leukemia 01/2022 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2021
2	Coinfection 01/2022 - 12/2020
2	Hypoxia (Hypoxemia) 01/2019 - 11/2009
2	Squamous Cell Carcinoma of Head and Neck 11/2009 - 06/2008
1	Microsatellite Instability 01/2023
1	Cross Infection (Nosocomial Infection) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Enterovirus Infections 12/2021
1	Hepatitis A (Hepatitis, Infectious) 01/2021
1	Carcinogenesis 01/2018
1	Mycoplasma Pneumonia 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2013
1	Retinal Neovascularization 09/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2012
1	Carcinoma (Carcinomatosis) 11/2009
1	Neoplasm Metastasis (Metastasis) 11/2009
1	Pathologic Neovascularization 06/2008

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 12/2023 - 01/2018
6	CD100 antigenIBA 01/2022 - 11/2009
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
3	RNA (Ribonucleic Acid)IBA 10/2022 - 11/2009
2	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2020
2	Neutralizing AntibodiesIBA 01/2021 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2018
2	Semaphorins (Semaphorin)IBA 01/2016 - 06/2008
2	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2016
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 12/2021
1	CytokinesIBA 12/2021
1	Inactivated VaccinesIBA 12/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	EnzymesIBA 01/2021
1	Viral RNAIBA 01/2021
1	Viral VaccinesIBA 12/2020
1	LuciferasesIBA 01/2019
1	NucleotidesIBA 01/2019
1	Initiator Codon (Start Codon)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	decursinIBA 09/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2012
1	Ethanol (Ethyl Alcohol)IBA 01/2012
1	SolutionsIBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2009
1	Oxygen (Dioxygen)IBA 11/2009

Therapy/Procedure

1	Therapeutics 01/2016
1	Intraperitoneal Injections 01/2012